Trademarkia Logo

Australia

AU$
Trademark Search
CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

View On IPO.GOV.AU

CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY
Protected: Registered/protected

Last updated on 12 Apr 2023

Owner Info

Seqirus Inc.

475 Green Oaks Parkway

Holly Springs NC 27540, UNITED STATES OF AMERICA

Serial Number

2298961 filed on 4 Aug 2022

Correspondent

Nadine H. Jacobson FROSS ZELNICK LEHRMAN & ZISSU, P.C.

151 WEST 42ND ST., 17TH FL.,

New York NY 10036,

UNITED STATES OF AMERICA

CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

Classification Information

Class [042]
Conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccines; providing information about the results of cl Read More

Class [044]
Pharmaceutical and medical information.

Mark Details

Serial Number

2298961

Registered On

4 Aug 2022

Renewal On

4 Aug 2032

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

11 Feb 2022

Mark Type

US

Legal History

Show more

Status DateAction Taken
12th Apr 2023Customer Amendment Made correspondence sent
12th Apr 2023Amendment to Address for Service Requested
23rd Nov 2022International Registration in Australia Protected correspondence sent
22nd Nov 2022IP Right Registration Published
22nd Nov 2022Status change to Registered/Protected
16th Sept 2022Application Accepted correspondence sent
15th Sept 2022IP Right has been Examined
15th Sept 2022IP Right Acceptance Published
15th Sept 2022Status change to Accepted
13th Sept 2022Awaiting examination